The stock of AIM ImmunoTech Inc (AMEX:AIM) last traded at $0.47, up 6.32% from the previous session.
AIM stock price is now 16.22% away from the 50-day moving average and -6.27% away from the 200-day moving average. The market capitalization of the company currently stands at $23.00M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
In other news, BRYAN NANCY, Director bought 38,462 shares of the company’s stock on Mar 21 ’24. The stock was bought for $15,000 at an average price of $0.39. Upon completion of the transaction, the Director now directly owns 38,462 shares in the company, valued at $18077.14. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 15 ’24, Director APPELROUTH STEWART bought 90,910 shares of the business’s stock. A total of $30,000 was incurred on buying the stock at an average price of $0.33. This leaves the insider owning 239,765 shares of the company worth $0.11 million. A total of 9.19% of the company’s stock is owned by insiders.
During the past 12 months, AIM ImmunoTech Inc has had a low of $0.32 and a high of $0.75. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 4.82, and a quick ratio of 4.82. The fifty day moving average price for AIM is $0.4064 and a two-hundred day moving average price translates $0.5031 for the stock.
The latest earnings results from AIM ImmunoTech Inc (AMEX: AIM) was released for Sep, 2023. According to the Biotechnology Company, earnings per share came in at -$0.16, missing analysts’ expectations of -$0.11 by -0.05. This compares to -$0.13 EPS in the same period last year. The net profit margin was -10764.25% and return on equity was -63.63% for AIM. The company reported revenue of $46000.0 for the quarter, compared to $21000.0 a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 119.05 percent. For the current quarter, analysts expect AIM to generate $40k in revenue.
